Impact of POR and CYP3A5 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in the Early Post-operative Period Following Kidney Transplantation-Reference-Cited by-同舟云学术

Impact of POR and CYP3A5 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in the Early Post-operative Period Following Kidney Transplantation

Published:2018-10 Issue:5 Volume:40 Page:549-557
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Phupradit Annop,Vadcharavivad Somratai,Ingsathit Atiporn,Kantachuvesiri Surasak,Areepium Nutthada,Sra-ium Supasil,Auamnoy Titinun,Sukasem Chonlaphat,Sumethkul Vasant,Kitiyakara Chagriya

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference46 articles.

1. KDIGO clinical practice guideline for the care of kidney transplant recipients;Am J Transplant.,2009

2. Therapeutic monitoring of calcineurin inhibitors for the nephrologist;Schiff;Clin J Am Soc Nephrol.,2007

3. Clinical pharmacokinetics of tacrolimus;Venkataramanan;Clin Pharmacokinet.,1995

4. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation;Staatz;Clin Pharmacokinet.,2004

5. The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation;Hesselink;Clin Pharmacokinet.,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of CYP3A4*22 and POR*28 variations on the pharmacokinetics of tacrolimus in renal transplant recipients: a meta-analysis of 18 observational studies;BMC Nephrology;2024-02-06

2. Effect of CYP3A4*22, CYP3A5*3 and POR*28 genetic polymorphisms on calcineurin inhibitors dose requirements in early phase renal transplant patients;Pharmacogenetics and Genomics;2023-12-04

3. Artificial Neural Network Analysis of Determinants of Tacrolimus Pharmacokinetics in Liver Transplant Recipients;Annals of Pharmacotherapy;2023-08-09

4. Tacrolimus pharmacokinetics are influenced by CYP3A5, age, and concomitant fluconazole in pediatric kidney transplant patients;Clinical and Translational Science;2023-06-26

5. Comparison of Tacrolimus Intra-Patient Variability during 6–12 Months after Kidney Transplantation between CYP3A5 Expressers and Nonexpressers;Journal of Clinical Medicine;2022-10-26